Cargando…

Unrecognized diabetes in critically ill COVID-19 patients

Detalles Bibliográficos
Autores principales:	Klein, Sebastian J., Fries, Dietmar, Kaser, Susanne, Mathis, Simon, Thomé, Claudius, Joannidis, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347252/ https://www.ncbi.nlm.nih.gov/pubmed/32646467 http://dx.doi.org/10.1186/s13054-020-03139-3

Ejemplares similares

Impaired fibrinolysis in critically ill COVID-19 patients
por: Bachler, Mirjam, et al.
Publicado: (2021)

Structured ICU resource management in a pandemic is associated with favorable outcome in critically ill COVID‑19 patients
por: Klein, Sebastian J., et al.
Publicado: (2020)

Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilation
por: Klein, Sebastian J., et al.
Publicado: (2021)

Safety of interhospital transfer for critically ill COVID-19 patients
por: Perschinka, Fabian, et al.
Publicado: (2023)

Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 year
por: Mayerhöfer, Timo, et al.
Publicado: (2021)

Plasma exchange in critically ill COVID-19 patients
por: Morath, Christian, et al.
Publicado: (2020)

Oliguria in critically ill patients: a narrative review
por: Klein, Sebastian J., et al.
Publicado: (2018)

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
por: Lackner, Nina, et al.
Publicado: (2022)

Diabetes Mellitus: An Unrecognized Complication in the Management of Patients With Mental Illness
por: Espinoza, Diana, et al.
Publicado: (2020)

Clinical phenotypes of critically ill COVID-19 patients
por: Azoulay, Elie, et al.
Publicado: (2020)

The presence of Pneumocystis jirovecii in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2021)

Predictive biomarkers of mortality in critically ill patients with COVID-19()
por: Sirvent, J.M., et al.
Publicado: (2022)

Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19
por: Lehner, Georg Franz, et al.
Publicado: (2020)

Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
por: Sakr, Yasser, et al.
Publicado: (2021)

Thromboelastography findings in critically ill COVID-19 patients
por: Salem, Nouran, et al.
Publicado: (2020)

Prone ventilation of critically ill adults with COVID-19: how to perform CPR in cardiac arrest?
por: Mędrzycka-Dąbrowska, Wioletta, et al.
Publicado: (2020)

Serum antibody response in critically ill patients with COVID-19
por: Longchamp, Alban, et al.
Publicado: (2020)

Tissue Plasminogen Activator in Critically Ill Adults with COVID-19
por: Douin, David J., et al.
Publicado: (2021)

Management and outcome of critically ill pregnant women with COVID-19
por: van Genderen, Michel E., et al.
Publicado: (2022)

Smoking in critically ill patients with COVID-19: the Australian experience
por: Plummer, Mark P., et al.
Publicado: (2023)

Biomass fuel and cataract: An unrecognized epidemic
por: Khanna, Rohit C
Publicado: (2020)

Variants of concern and clinical outcomes in critically ill COVID-19 patients
Publicado: (2023)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
por: Bradbury, Charlotte A., et al.
Publicado: (2023)

Association of Obesity With More Critical Illness in COVID-19
por: Sharma, Abhishek, et al.
Publicado: (2020)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

Hyperglycemia in Acute Critically Ill COVID-19 Patients
por: Cilloniz, Catia, et al.
Publicado: (2023)

Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients
por: Talan, Leyla, et al.
Publicado: (2022)

Critical Illness Polyneuropathy as a Sequelae of COVID-19
por: Bawiskar, Nipun, et al.
Publicado: (2022)

Pneumothorax in hair dye poisoning: An unrecognized danger
por: Senthilkumaran, Subramanian, et al.
Publicado: (2011)

Gut microbiota status in leptospirosis: An unrecognized player?
por: Petakh, Pavlo, et al.
Publicado: (2022)

Organizational aspects of care associated with mortality in critically ill COVID-19 patients
por: Rimmelé, Thomas, et al.
Publicado: (2020)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients
por: Meersseman, Philippe, et al.
Publicado: (2021)

Should critically ill patients with COVID-19 be managed in high-volume ICUs?
por: Ramanan, Mahesh, et al.
Publicado: (2023)

Diabetes mellitus is associated with 90-day mortality in old critically ill COVID-19 patients: a multicenter prospective observational cohort study
por: Mayerhöfer, Timo, et al.
Publicado: (2023)

Severe neurological complications in critically ill COVID-19 patients
por: Notz, Quirin, et al.
Publicado: (2020)

Psychological support to relatives of critically ill patients with COVID-19
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2020)

Not only pulmonary rehabilitation for critically ill patients with COVID-19
por: Estraneo, Anna, et al.
Publicado: (2020)

Clinical features of critically ill patients with confirmed COVID-19
por: Chu, Yanan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_simg41t3982gihsko241mb36r6